Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DANBLOCK: Beta-Blockers After MI with Preserved EF
NCT03778554Phase 4Active, not recruiting
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Dec 2018
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carvedilol in myocardial infarction (MI), sponsored by Bispebjerg and Frederiksberg Hospital. Started Dec 2018; status: active, not recruiting.
02
Drugs
carvedilol
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT03778554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03778554.